Ryoichi Ishibashi, Yoko Takatsuna, Masaya Koshizaka, Tomoaki Tatsumi, Sho Takahashi, Kengo Nagashima, Ko Ishikawa, Tomomi Kaiho, Noriko Asaumi, Takayuki Baba, et al. Ranibizumab with luseogliflozin in type 2 diabetes with diabetic macular oedema: A randomised clinical trial. Diabetes, obesity & metabolism. 2025
Kiichi Hirayama, Masaya Koshizaka, Ryoichi Ishibashi, Mayumi Shoji, Takuro Horikoshi, Kenichi Sakurai, Koutaro Yokote. Effects of the SGLT2 inhibitor ipragliflozin and metformin on hepatic steatosis and liver fibrosis: Sub-analysis of a randomized controlled study. Diabetes, obesity & metabolism. 2025
Ryo Terayama, Masaya Koshizaka, Yoshiro Maezawa, Takahisa Shibata, Toshiaki Ban, Koutaro Yokote. Predictive risk factors for early-stage renal dysfunction: An analysis of specific health checkup data for the general Japanese population. Nutrition, metabolism, and cardiovascular diseases : NMCD. 2024. 103813-103813
Kazuto Aono, Masaya Koshizaka, Mayumi Shoji, Hiyori Kaneko, Yukari Maeda, Hisaya Kato, Yoshiro Maezawa, Makoto Miyabayashi, Mai Ishikawa, Akiko Sekiguchi, et al. Less frequent skin ulcers among patients with Werner syndrome treated with pioglitazone: findings from the Japanese Werner Syndrome Registry. Aging. 2024. 16
Mayumi Shoji, Naoya Teramoto, Takahiro Ishikawa, Aiko Hayashi, Ai Matsumoto, Hidetoshi Ochiai, Ayano Yamaguchi, Yukari Maeda, Atsushi Takasaki, Chihiro Hiraga, et al. Hypoalbuminemia on admission in diabetic patients correlates with severity of illness in COVID-19: A retrospective clinical study and literature review. Endocrine and Metabolic Science. 2024. 16. 100196-100196